GOC’s 16th Annual CPD Meeting
It is with great pleasure that we invite you on behalf of the Executive of the Society of Gynecologic Oncology of Canada and the CPD Program Planning Committee to attend the 16th Annual Continuing Professional Development meeting in Toronto, Ontario April 29-30, 2016 at the Sheraton Centre Toronto Hotel. We have an outstanding array of Canadian and international speakers who will be presenting on a variety of exciting topics including:
- Endometrial Cancer: From Diagnosis to Treatment
- Challenging Topics We Face in Clinic
- HPV-Related Diseases After HPV Vaccination
- Management of Low Grade Ovarian Cancer
- Palliative Care in Gynecologic Oncology
- Prepping for PARP Inhibitors
- Nursing Symposium Intro to BRCA and Nursing Management of Side Effects related to PARP Therapy
We've also expanded our program to include a course for fellows and attendings on Untangling the genome: Improving our Understanding of Genomics in Gyn Cancers
Sign-up now for this year's outstanding program!
April 28, 2016 - April 30, 2016
Sheraton Toronto Centre Hotel
123 Queen Street, W., Toronto, Ontario
Host: The Society of Gynecologic Oncology of Canada
Contact E-Mail: email@example.com
- To describe the pathology challenges that exist with the diagnosis of endometrial cancer
- To discuss the role of surgery as it pertains to endometrial cancer management, in particular the role of sentinel lymph node evaluation
- To describe the indications for radiotherapy as adjuvant therapy in both low grade and high grade endometrial cancer
- To discuss the role of chemotherapy as adjuvant treatment for all stages of endometrial cancer
- To summarize the pharmacokinetics, indications/contraindications, safety/toxicity, and practical prescribing guidelines of medical marijuana
- To describe the medico-legal aspects surrounding physician assisted suicide
- To discuss the burden of HPV-related disease after HPV vaccination
- To review the management of low grade ovarian cancer, including chemotherapy, surgery, heated intraperitoneal chemotherapy (HIPEC), and new targeted agents
- To describe updates in the management of malignant ovarian germ cell tumours
- To summarize the practical aspects of prescribing PARP inhibitors
- To describe the importance of the nursing role in education around BRCA testing for ovarian cancer patients and their family members
- To review the nursing role in side effect management of common toxicities for patients receiving emerging Parp inhibitors
- To improve our understanding of genomics in gynecological cancers
Friday, April 29, 2016
Sheraton Toronto Centre Hotel, Civic Ballroom
Welcome and announcements
Paul Hoskins, MD SESSION I ~ ENDOMETRIAL CANCER: FROM DIAGNOSIS TO TREATMENT 800-845
Subclassification of endometrial carcinomas
Martin Koebel, MD 845-930
Sentinel node mapping in endometrial cancer
Nadeem Abu Rustum, MD 930-1015
Radiotherapy for endometrial cancer
Boris Bahoric, MD 1015-1100
SPONSOR EXHIBITS AND NETWORKING
Systemic treatment of endometrial cancer
Helen MacKay, MD SESSION II ~ CHALLENGES WE FACE IN CLINIC 1130-1210
Medical cannabis in cancer care: clearing away the smoke
Marcia Gillman, MD 1210-1250
Medical-legal issues of end of life care
Steven J. Bellemare, MD 1250-1340
City Hall Room LUNCH
SESSION III ~ CERVICAL CANCER 1340-1410
HPV-related disease post vaccination
James Bentley, MD SESSION IV ~ OVARIAN CANCER 1410-1420
The evolving role of Ovarian Cancer Canada
Kelly Grover 1420-1520
Management challenges of low-grade serous ovarian/peritoneal cancer
David M. Gershenson, MD 1520-1550
SPONSOR EXHIBITS AND NETWORKING
Management of malignant ovarian germ cell tumors and ovarian sex cord-stromal tumors
David M. Gershenson, MD 1615-1700
Prepping for PARP inhibitors: the practical aspects
Paul Hoskins, MD 1700
Final announcements and adjournment
Paul Hoskins, MD GOC SOCIAL EVENT – ARCADIAN LOFT 1800 Cocktail reception
1900 Leadership lecture
Mohamed Fahmy, Canadian journalist, Adjunct Professor, School of Journalism and Population and Public Health, University of British Columbia Saturday, April 30, 2016
Sheraton Toronto Centre Hotel, City Hall Room
Speaker SESSION V ~ THE GYNE ONCOLOGY NURSE ROLE IN BRCA 1/2 TESTING & PARP THERAPY 815-830
Breakfast and introductions
Joanne Power 850-915
The GOC Nursing Professional Practice Committee: an active Community of Practice
Joanne Power 915-945
What is the evolving role of BRCA1/2 in ovarian cancer treatment and how does the nursing role adapt to advances in precision medicine?
Heidi Thomas 945-1015
Coffee and networking
Navigating PARP inhibitors: a nurse’s view
Valerie Bowering 1125-1130
Wrap-up and program evaluations
Saturday, April 30, 2016
900-1500 ~ CCTG Gynecological Disease Site Committee Meeting Saturday, April 30, 2016
Sheraton Toronto Centre Hotel, City Hall Room
Speaker SESSION VI ~ GOC COURSE ~ UNTANGLING THE GENOME: IMPROVING OUR UNDERSTANDING OF GENOMIC IN GYN CANCERS 1530-1730 The biology of cancer course: Introduction Gabe DiMattia, PhD The R and R of DNA: The superstructure of DNA and associated proteins, Mechanisms of DNA Replication and Repair. Jean-Yves Masson, PhD The generation gap: What we can discern about the genome from next generation sequencing Dr. Trevor Pugh Finding the mutants in Ninja: mutation significance in the disrupted cancer genome Dr. Mark Carey The impact of next generation sequencing on Familial Cancer Diagnosis. Dr. Intan Schrader
Registration Category Reg fee until
Reg fee as of
GOC member physicians $250.00 $340.00 GOC member fellows, nurses, residents, researchers, pharmacists $150.00 $240.00 Non-member physicians $450.00 $540.00 Non-member fellows, nurses, residents, researchers, pharmacists $200.00 $290.00 Retired GOC Members $ 75.00 $170.00
How do I register?
Register on-line. Click on the Register Now button on this page.
Avoid the late payment fee and register by March 28th!
Cancellation and Refund policy: Fees to attend the CPD conference will be refunded if a written notice of cancellation is received no later than April 11, 2016. An administration fee of $50 will apply. Refunds will not be granted after this date.
The cost of dinner will be refunded if a written notice of cancellation is received no later than April 22, 2016. An administration fee of $25 will apply. Refunds will not be granted after this date.
Registration for this event is closed.
Accomodations & Travel
GOC has negotiated conference rates for travel and accommodations.
Sheraton Toronto Centre123 Queen Street, W.
Toronto, ON M5H 2M9
The GOC has reserved a block of rooms at the Sheraton Centre Toronto Hotel at a special conference rate of $170 per night plus applicable taxes and other charges. To benefit from this rate, you will need to make your reservation by March 28, 2016, and identify yourself as being with the Society of Gynecologic Oncology of Canada – 2016.
A deposit equal to one night’s stay is required to hold your reservation. A refund of this deposit will be given to cancellations received until 72 hours prior to arrival.
On-line reservation: Click here to reserve your room online.
Toll-free Sheraton reservations: 1-888-627-7175
Direct to hotel: 1-416-361-1000
Rate informationRooms start at $170.00 per night
Save 10% with Air Canada on Flex, Latitude and Business Flexible classes.
Click here to book your flight online and enter the special promotion code FT77ZH91.
Porter Airlines is proud to offer a 15% discount on all available base fares (with the exception of the lowest class fare during a public seat sale) for travel to and from the GOC’s 16th Annual CPD Meeting.
Click here to book your flight online and enter the special promotion code GOC16.
We would like to acknowledge the following companies for their support of our 16th Annual Continuing Professional Development Meeting in the form of sponsorship or educational grants:
DIAMOND: Astra Zeneca
PLATINUM: Hoffmann-La Roche
GOLD: Merck Canada
SILVER: Minogue Medical Inc.
OTHER SPONSORS: Bayshore Specialty Rx | CannTrust | Novadaq | Tribe Medical Group